Omeros (OMER) EBITDA Margin Growth (3y) (2013 - 2022)
Powered by 
Analysis
Omeros (OMER) EBITDA Margin Growth (3y) (2013 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -2,649.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 30,461.00 |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -33,570.00 |
| Mar 31, 2022 | -41,261.00 |
| Dec 31, 2021 | -5,513.00 |
| Sep 30, 2021 | 63,640.00 |
| Jun 30, 2021 | 169,173.00 |
| Mar 31, 2021 | 152,860.00 |
| Dec 31, 2020 | -21,544.00 |
| Sep 30, 2020 | -7,378.00 |
| Jun 30, 2020 | -13,497.00 |
| Mar 31, 2020 | 322.00 |
| Dec 31, 2019 | 2,095.00 |
| Sep 30, 2019 | 6,945.00 |
| Jun 30, 2019 | 7,434.00 |
| Mar 31, 2019 | 17,385.00 |
| Dec 31, 2018 | 18,635.00 |
| Sep 30, 2018 | -17,690.00 |
| Jun 30, 2018 | -134,897.00 |
| Mar 31, 2018 | 287,749.00 |
| Dec 31, 2017 | 1.10 Mn |
| Sep 30, 2017 | 798,201.00 |